Elgemtumab (anti-ERBB3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182826-100ΜG / 100ΜG
CAS：1512559-37-3
Elgemtumab (anti-ERBB3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182826-10MG / 10MG
CAS：1512559-37-3
Elgemtumab (anti-ERBB3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182826-1MG / 1MG
CAS：1512559-37-3
Elgemtumab (anti-ERBB3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182826-5MG / 5MG
CAS：1512559-37-3
Frovocimab (anti-PCSK9) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182827-100ΜG / 100ΜG
CAS：1643672-70-1
Frovocimab (anti-PCSK9) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182827-10MG / 10MG
CAS：1643672-70-1
Frovocimab (anti-PCSK9) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182827-1MG / 1MG
CAS：1643672-70-1
Frovocimab (anti-PCSK9) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182827-5MG / 5MG
CAS：1643672-70-1
Lodapolimab (anti-PD-L1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182828-100ΜG / 100ΜG
CAS：2118349-31-6
Lodapolimab (anti-PD-L1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182828-10MG / 10MG
CAS：2118349-31-6
Lodapolimab (anti-PD-L1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182828-1MG / 1MG
CAS：2118349-31-6
Lodapolimab (anti-PD-L1) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182828-5MG / 5MG
CAS：2118349-31-6
Tavolixizumab (anti-CD134) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182830-100ΜG / 100ΜG
CAS：1635395-25-3
Tavolixizumab (anti-CD134) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182830-10MG / 10MG
CAS：1635395-25-3
Tavolixizumab (anti-CD134) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182830-1MG / 1MG
CAS：1635395-25-3
Tavolixizumab (anti-CD134) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182830-5MG / 5MG
CAS：1635395-25-3
Prasinezumab (anti-Alpha-synuclein) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182835-100ΜG / 100ΜG
CAS：1960462-19-4
Prasinezumab (anti-Alpha-synuclein) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182835-10MG / 10MG
CAS：1960462-19-4
Prasinezumab (anti-Alpha-synuclein) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182835-1MG / 1MG
CAS：1960462-19-4
Prasinezumab (anti-Alpha-synuclein) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182835-5MG / 5MG
CAS：1960462-19-4
Odronextamab (anti-CD20&CD3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB182836-100ΜG / 100ΜG
CAS：1801338-64-6
Odronextamab (anti-CD20&CD3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB182836-10MG / 10MG
CAS：1801338-64-6
Odronextamab (anti-CD20&CD3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB182836-1MG / 1MG
CAS：1801338-64-6
Odronextamab (anti-CD20&CD3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥90%(SDS-PAGE&SEC), Lot by Lot
AB182836-5MG / 5MG
CAS：1801338-64-6
Fianlimab (anti-LAG3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182837-100ΜG / 100ΜG
CAS：2126132-98-5
Fianlimab (anti-LAG3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182837-10MG / 10MG
CAS：2126132-98-5
Fianlimab (anti-LAG3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182837-1MG / 1MG
CAS：2126132-98-5
Fianlimab (anti-LAG3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182837-5MG / 5MG
CAS：2126132-98-5
Pozelimab (anti-Complement C5) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182838-100ΜG / 100ΜG
CAS：2096328-94-6
Pozelimab (anti-Complement C5) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182838-10MG / 10MG
CAS：2096328-94-6
Pozelimab (anti-Complement C5) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182838-1MG / 1MG
CAS：2096328-94-6
Pozelimab (anti-Complement C5) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182838-5MG / 5MG
CAS：2096328-94-6
Semorinemab (anti-Tau) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182842-100ΜG / 100ΜG
CAS：2159141-27-0
Semorinemab (anti-Tau) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182842-10MG / 10MG
CAS：2159141-27-0
Semorinemab (anti-Tau) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182842-1MG / 1MG
CAS：2159141-27-0
Semorinemab (anti-Tau) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182842-5MG / 5MG
CAS：2159141-27-0
Olinvacimab (anti-VEGFR2) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182846-100ΜG / 100ΜG
CAS：2095504-49-5
Olinvacimab (anti-VEGFR2) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182846-10MG / 10MG
CAS：2095504-49-5
Olinvacimab (anti-VEGFR2) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182846-1MG / 1MG
CAS：2095504-49-5
Olinvacimab (anti-VEGFR2) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182846-5MG / 5MG
CAS：2095504-49-5
Cobolimab (anti-TIM-3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182847-100ΜG / 100ΜG
CAS：2022215-65-0
Cobolimab (anti-TIM-3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182847-10MG / 10MG
CAS：2022215-65-0
Cobolimab (anti-TIM-3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182847-1MG / 1MG
CAS：2022215-65-0
Cobolimab (anti-TIM-3) ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
AB182847-5MG / 5MG
CAS：2022215-65-0
Tidutamab (anti-CD3&SSTR2) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB182850-100ΜG / 100ΜG
CAS：2148354-90-7
Tidutamab (anti-CD3&SSTR2) 無載體, 重組, ExactAb™, 低內毒素, 無疊氮鈉, 已驗證, ≥90%(SDS-PAGE&SEC-HPLC), Lot by Lot
AB182850-10MG / 10MG
CAS：2148354-90-7
